Key Spec Table
|Species Reactivity||Key Applications||Host||Format||Antibody Type|
|H, M, R||WB, ICC, IH(P)||Rb||Unpurified||Monoclonal Antibody|
|Presentation||Rabbit Monoclonal in buffer containing sodium azide, glycerol, and BSA.|
|Safety Information according to GHS|
|Material Size||100 µL|
|Reference overview||Pub Med ID|
|SREBP-1 transcription factors regulate skeletal muscle cell size by controlling protein synthesis through myogenic regulatory factors.|
Dessalle, K; Euthine, V; Chanon, S; Delarichaudy, J; Fujii, I; Rome, S; Vidal, H; Nemoz, G; Simon, C; Lefai, E
PloS one 7 e50878 2012
SREBP-1 are ubiquitously expressed transcription factors, strongly expressed in lipogenic tissues where they regulate several metabolic processes like fatty acid synthesis. In skeletal muscle, SREBP-1 proteins regulate the expression of hundreds of genes, and we previously showed that their overexpression induced muscle atrophy together with a combined lack of expression of myogenic regulatory factors. Here we present evidences that SREBP-1 regulate muscle protein synthesis through the downregulation of the expression of MYOD1, MYOG and MEF2C factors. In myotubes overexpressing SREBP-1, restoring the expression of myogenic factors prevented atrophy and rescued protein synthesis, without affecting SREBP-1 action on atrogenes and proteolysis. Our results point out the roles of MRFs in the maintenance of the protein content and cell size in adult muscle fibre, and contribute to decipher the mechanisms by which SREBP-1 regulate muscle mass.
|Mechanistic insight into WEB-2170-induced apoptosis in human acute myelogenous leukemia cells: the crucial role of PTEN.|
Cellai, Cristina, et al.
Exp. Hematol., 37: 1176-1185.e21 (2009) 2009
This study aimed to investigate the mechanisms of action of WEB-2170, an inverse agonist of platelet-activating factor receptor, capable of inducing apoptosis in human acute myelogenous leukemia (AML) cells.